Showing results (71-80 of 283) with videos related to
Sort By:
Pageof 29
Nanomaterials (Basel, Switzerland)|November 6, 2019
Nanotechnology in Oral Cavity Carcinoma: Recent Trends and Treatment OpportunitiesFrancesca De Felice, Costanza Cavallini, Alberta Barlattani, et al.Medical Oncology (Northwood, London, England)|June 14, 2019
Hypofractionated radiotherapy combined with cetuximab in vulnerable elderly patients with locally advanced head and neck squamous cell carcinomaFrancesca De Felice, Luigia Vetrone, Nadia Bulzonetti, et al.La Radiologia Medica|December 31, 2022
Are you planning to be a radiation oncologist? A survey by the young group of the Italian Association of Radiotherapy and Clinical Oncology (yAIRO)Valerio Nardone, Luca Boldrini, Viola Salvestrini, et al.Clinical Colorectal Cancer|March 9, 2016
Disease Control, Survival, and Toxicity Outcome After Intensified Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: A Single-Institution ExperienceFrancesca De Felice, Daniela Musio, Anna Lisa Magnante, et al.Journal of Immunology Research|August 4, 2015
Immunotherapy of Ovarian Cancer: The Role of Checkpoint InhibitorsFrancesca De Felice, Claudia Marchetti, Innocenza Palaia, et al.International Journal of Colorectal Disease|January 9, 2019
Prognostic significance of inflammatory-related parameters in patients with anal canal cancerFrancesca De Felice, Filippo Lorenzo Rubini, Luca Romano, et al.BMC Cancer|May 14, 2017
Clinical benefit of adding oxaliplatin to standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a meta-analysis : Oxaliplatin in neoadjuvant treatment for rectal cancerFrancesca De Felice, Ilaria Benevento, Anna Lisa Magnante, et al.Expert Review of Anticancer Therapy|November 13, 2020
Pembrolizumab for advanced cervical cancer: safety and efficacyFrancesca De Felice, Elena Giudice, Giulia Bolomini, et al.In Vivo (Athens, Greece)|September 13, 2022
Synchronous Anal Canal Cancer and Cervical Cancer: Report of a Case and Management ImplicationCarlo Guglielmo Cattaneo, Daniela Musio, Federica Tanzi, et al.Cancer Treatment and Research Communications|January 22, 2022
Hyperthermic intraperitoneal chemotherapy (HIPEC) after primary debulking surgery in advanced epithelial ovarian cancer: Is BRCA mutational status making the difference?Valentina Ghirardi, Francesca De Felice, Marco D'Indinosante, et al.Pageof 29